Rebecca Wilkins, DVP R&D Neuromodulation for Abbott, discusses the Eterna SCS, strategies for penetr...
While the macro environment is improving, some neuromodulation companies and segments navigated choppy w...
Saluda Medical President and CEO Jim Schuermann discusses the Company, the Evoke System and changing the...
Medtronic executives Nnamdi Njoku and Charlie Covert discuss Medtronic’s latest initiatives in Neuromodu...
SmartTRAK takes a look back at Neuromodulation Trends in 2022 and looks forward to reporting on emerging...
Growth in the SCS and DBS segments remained soft in Q322 as companies continue to wrestle with macro-env...